Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicacions

  • Mancikova V; Castelblanco E; Pineiro-Yanez E; Perales-Paton J; de Cubas AA; Inglada-Perez L; Matias-Guiu X; Capel I; Bella M; Lerma E; Riesco-Eizaguirre G; Santisteban P; Maravall F; Mauricio D; Al-Shahrour F; Robledo M

    MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors

    Modern Pathology 28 748-757. .

    [doi:10.1038/modpathol.2015.44]

  • Eritja N; Santacana M; Maiques O; Gonzalez-Tallada X; Dolcet X; Matias-Guiu X

    Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: Endometrial cancer as a model

    Methods 77-78 31-40. .

    [doi:10.1016/j.ymeth.2014.11.001]

  • Alonso-Alconada, L.; Santacana, M.; Garcia-Sanz, P.; Muinelo-Romay, L.; Colas, E.; Mirantes, C.; Monge, M.; Cueva, J.; Oliva, E.; Soslow, R.A.; Lopez, M.A.; Palacios, J.; Prat, J.; Valls, J.; Krakstad, C.; Salvesen, H.; Gil-Moreno, A.; Lopez-Lopez, R.; Dolcet, X.; Moreno-Bueno, G.; Reventos, J.; Matias-Guiu, X.; Abal, M.

    Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    INTERNATIONAL JOURNAL OF CANCER 136 1863-1873. .

    [doi:10.1002/ijc.29213]

  • Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F

    Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas

    VIRCHOWS ARCHIV 466 415-422. .

    [doi:10.1007/s00428-015-1728-5]

  • Chacon, A; Vilar, A; Arroyo, D; Sarro, F; Craver, L; Ros, S; Lopez, C; Castillo, A; Matias-Guiu, X; Fernandez-Giraldez, E

    Acute kidney failure secondary to very severe hypercalcaemia from primary hyperparathyroidism

    Nefrologia 35 224-226. .

  • Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X

    A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    HUMAN PATHOLOGY 45 2394-2403. .

    [doi:10.1016/j.humpath.2014.06.031]

  • Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M

    ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

    CARCINOGENESIS 35 2679-2686. .

    [doi:10.1093/carcin/bgu198]

  • Alonso-Alconada, Lorena; Muinelo-Romay, Laura; Madissoo, Kadri; Diaz-Lopez, Antonio; Krakstad, Camilla; Trovik, Jone; Wik, Elisabeth; Hapangama, Dharani; Coenegrachts, Lieve; Cano, Amparo; Gil-Moreno, Antonio; Chiva, Luis; Cueva, Juan; Vieito, Maria; Ortega, Eugenia; Mariscal, Javier; Colas, Eva; Castellvi, Josep; Cusido, Maite; Dolcet, Xavier; Nijman, Hans W.; Bosse, Tjalling; Green, John A.; Romano, Andrea; Reventos, Jaume; Lopez-Lopez, Rafael; Salvesen, Helga B.; Amant, Frederic; Matias-Guiu, Xavier; Moreno-Bueno, Gema; Abal, Miguel; ENITEC Consortium

    Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

    MOLECULAR CANCER 13 -. .

    [doi:10.1186/1476-4598-13-223]

  • Maiques, O.; Cuevas, D.; García Dios, D.A.; Coenegrachts, L.; Santacana, M.; Velasco, A.; Romero, M.; Gatius, S.; Lambrechts, D.; Müller, S.; Pedersen, H.C.; Dolcet, X.; Amant, F.; Matias-Guiu, X.

    FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA

    Histopathology 65 371-388. .

    [doi:10.1111/his.12396]

  • Mancikova, V; Buj, R; Castelblanco, E; Inglada-Perez, L; Diez, A; de Cubas, AA; Curras-Freixes, M; Maravall, FX; Mauricio, D; Matias-Guiu, X; Puig-Domingo, M; Capel, I; Bella, MR; Lerma, E; Castella, E; Reverter, JL; Peinado, MA; Jorda, M; Robledo, M

    DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival

    INTERNATIONAL JOURNAL OF CANCER 135 598-610. .

    [doi:10.1002/ijc.28703]

  • Pulido, R.; Baker, S.J.; Barata, J.T.; Carracedo, A.; Cid, V.J.; Chin-Sang, I.D.; Davé, V.; Den Hertog, J.; Devreotes, P.; Eickholt, B.J.; Eng, C.; Furnari, F.B.; Georgescu, M.-M.; Gericke, A.; Hopkins, B.; Jiang, X.; Lee, S.-R.; Lösche, M.; Malaney, P.; Matias-Guiu, X.; Molina, M.; Pandolfi, P.P.; Parsons, R.; Pinton, P.; Rivas, C.; Rocha, R.M.; Rodríguez, M.S.; Ross, A.H.; Serrano, M.; Stambolic, V.; Stiles, B.; Suzuki, A.; Tan, S.-S.; Tonks, N.K.; Trotman, L.C.; Wolff, N.; Woscholski, R.; Wu, H.; Leslie, N.R.

    A Unified Nomenclature and Amino Acid Numbering for Human PTEN

    SCIENCE SIGNALING 7 -. .

    [doi:10.1126/scisignal.2005560]

  • Moreno, S.; Forcada, P.; Soria, X.; Altemir, V.; Gatius, S.; Gil, M.; Matías-Guiu, X.; Casanova, J.M.; Martí, R.M.

    Tenosynovitis with rice body formation presenting as a cutaneous abscess

    JOURNAL OF CUTANEOUS PATHOLOGY 41 602-605. .

    [doi:10.1111/cup.12316]

Projectes

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU